Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose-Response Relationship”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01235000
What this trial is testing

TIV Infant/Toddler Response Evaluation - Follow-up for Influenza B Boost

Who this might be right for
Influenza
British Columbia Centre for Disease Control 30
Early research (Phase 1)Study completedNCT03837093
What this trial is testing

Low-dose IL-2 to the Kinetics of Regulatory T-cell in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Assistance Publique - Hôpitaux de Paris 40
Testing effectiveness (Phase 2)Study completedNCT03692403
What this trial is testing

Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related Pain

Who this might be right for
Endometriosis-related Pain
Ferring Pharmaceuticals 22
Testing effectiveness (Phase 2)Study completedNCT00920387
What this trial is testing

Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy in People With Illness-related Anxiety

Who this might be right for
Anxiety
Multidisciplinary Association for Psychedelic Studies 12
Not applicableStudy completedNCT02247024
What this trial is testing

Pupil Response in Patients on Opioids.

Who this might be right for
Chronic PainImpaired Pupillary ReflexOpioid-Related Disorders
Oslo University Hospital 63
Testing effectiveness (Phase 2)Ended earlyNCT02780180
What this trial is testing

QUantum Genomics Incremental Dosing in Heart Failure - QUID-HF

Who this might be right for
Heart Failure
Quantum Genomics SA 23
Not applicableStudy completedNCT04128566
What this trial is testing

MechSens - Dose-response Relationship of in Vivo Ambulatory Load and Mechanosensitive Cartilage Biomarkers

Who this might be right for
Articular Cartilage Degeneration
University Hospital, Basel, Switzerland 87
Early research (Phase 1)Study completedNCT00002231
What this trial is testing

Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers

Who this might be right for
HIV InfectionsHIV Seronegativity
Wyeth-Lederle Vaccines
Testing effectiveness (Phase 2)Study completedNCT00000825
What this trial is testing

The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Testing effectiveness (Phase 2)Study completedNCT01977482
What this trial is testing

Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia

Who this might be right for
Anaemia
GlaxoSmithKline 216
Testing effectiveness (Phase 2)Study completedNCT01426386
What this trial is testing

A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment

Who this might be right for
Infertility
Ferring Pharmaceuticals 265
Early research (Phase 1)Study completedNCT00001090
What this trial is testing

A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected Volunteers

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT00002218
What this trial is testing

A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients

Who this might be right for
HIV Infections
Parke-Davis 40
Testing effectiveness (Phase 2)UnknownNCT03651375
What this trial is testing

Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall

Who this might be right for
SarcomaFibrosarcomaLeiomyosarcoma+14 more
Maria Sklodowska-Curie National Research Institute of Oncology 46
Not applicableStudy completedNCT06358781
What this trial is testing

A Dose-response Study to Validate the Biomarkers for Whole Grain Dietary Intake

Who this might be right for
Chronic Disease Prevention
Peking University 38
Testing effectiveness (Phase 2)UnknownNCT00002219
What this trial is testing

Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children

Who this might be right for
HIV Infections
Gilead Sciences 36
Early research (Phase 1)Study completedNCT00006207
What this trial is testing

Safety and Tolerability of the Vaginal Gel PRO 2000/5

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Post-approval studies (Phase 4)Study completedNCT01057381
What this trial is testing

Dexmedetomidine in Pediatric Tonsillectomy

Who this might be right for
Pediatric AdenotonsillectomyPost Operative Analgesia
Baylor College of Medicine 109
Testing effectiveness (Phase 2)Ended earlyNCT03863288
What this trial is testing

Dose Response Relationship of Oxytocin on Irritability in Youths

Who this might be right for
Irritable Mood
University of Nebraska 60
Large-scale testing (Phase 3)Study completedNCT00710866
What this trial is testing

Influenza Vaccine Dose-Response in Infants and Toddlers: Immunogenicity and Reactogenicity

Who this might be right for
Influenza
British Columbia Centre for Disease Control 262
Next Page